Physician

Gizelle Stevens, MD

According to 2025 Medicare claims, Gizelle Stevens, MD (NPI: 1396150827) practices pulmonary disease in the Anniston-Oxford, AL market, with the plurality of this provider's patient population coming from Calhoun, AL. This provider's primary affiliated billing organization is REGIONAL HEALTH MANAGEMENT CORPORATION (NPI: 1639466584; TIN: 63-0819576) and primary practice location at 36207-4716. Stevens is affiliated with the Advanced Doctors ACO, LLC (ACO ID: A4794), participating under the MSSP model.

Stevens' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 595 traditional Medicare patients, billed 2,792 HCPCS/CPT codes, and received $162,776 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 5,421 prescription claims across 643 beneficiaries totaling $2,545,306 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 2,561 claims. Open Payments data shows 13 records totaling $363. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $27,613 to $2,545,306. For DME billing, reported payments moved sharply higher in recent years, from $1,456 to $149,650.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	198	620	$43,950
2021	385	1,609	$139,624
2022	702	4,077	$287,984
2023	728	3,447	$257,703
2024	595	2,792	$162,776

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	38	171	$27,613
2016	39	106	$5,324
2017	56	197	$13,243
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	39	135	$23,474
2021	133	723	$171,888
2022	542	4,046	$1,953,464
2023	655	5,391	$2,662,778
2024	643	5,421	$2,545,306

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$88
2021	N/R	302	$37,538
2022	474	1,554	$98,249
2023	742	2,626	$173,131
2024	768	2,561	$166,045

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	114	273	$146
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	185	548	$82
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	243	419	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	192	240	$63
94010	Test to measure expiratory airflow and volume	121	121	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	1,030	36,864	$783,538
Ofev	Nintedanib Esylate	32	960	$409,732
Opsumit	Macitentan	22	660	$278,271
Fasenra Pen	Benralizumab	27	1,512	$162,998
Tezspire	Tezepelumab-Ekko	38	1,084	$161,027

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	50	$42,978
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	57	456	$38,451
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	15	$11,320
E1392	Portable oxygen concentrator, rental	Y	35	266	$9,492
A7031	Face mask interface, replacement for full face mask, each	N	38	74	$7,168

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$363	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gizelle Stevens, MD?

Tedicare shows public-source Medicare data for Gizelle Stevens, MD (NPI 1396150827), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gizelle Stevens, MD have ACO affiliation data?

Gizelle Stevens, MD is shown with ACO affiliation data for Advanced Doctors ACO, LLC (MSSP, ACO ID A4794).

What billing organization is linked to Gizelle Stevens, MD?

Gizelle Stevens, MD is linked to REGIONAL HEALTH MANAGEMENT CORPORATION (billing NPI 1639466584) in the available physician profile data.

Does Gizelle Stevens, MD have Open Payments data?

Gizelle Stevens, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.